DEUTSCHE BANK AG\ - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 60 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.9%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2017$11,000
-21.4%
4,444
-45.4%
0.00%
Q3 2017$14,000
+27.3%
8,144
+24.1%
0.00%
Q2 2017$11,000
+22.2%
6,560
+27.4%
0.00%
Q1 2017$9,000
-92.7%
5,150
-74.6%
0.00%
Q4 2016$123,000
-60.6%
20,291
-38.8%
0.00%
Q3 2016$312,000
+155.7%
33,165
+98.1%
0.00%
Q2 2016$122,000
-43.8%
16,743
-43.1%
0.00%
Q1 2016$217,000
-35.0%
29,433
-0.5%
0.00%
Q4 2015$334,000
+255.3%
29,585
+195.8%
0.00%
Q3 2015$94,00010,0000.00%
Other shareholders
INOTEK PHARMACEUTICALS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Devon Park Associates, LLC 3,243,709$36,751,000100.00%
RHO CAPITAL PARTNERS INC 2,627,790$29,773,00010.24%
Private Capital Advisors, Inc. 341,000$3,864,0001.67%
NEXTHERA CAPITAL LP 42,000$476,0000.68%
SPHERA FUNDS MANAGEMENT LTD. 360,000$4,079,0000.60%
SENZAR ASSET MANAGEMENT, LLC 309,600$3,507,768,0000.39%
Graticule Asia Macro Advisors LLC 148,000$1,676,0000.27%
FT Options LLC 26,421$299,0000.22%
EAM Investors, LLC 128,911$1,461,0000.19%
Tekla Capital Management LLC 425,000$4,815,0000.18%
View complete list of INOTEK PHARMACEUTICALS CORP shareholders